Semaglutide 10 units refer to a specific dosage of the medication, which is a glucagon-like peptide-1 (GLP-1) receptor agonist. This formulation is used for the management of type 2 diabetes. When administered as a subcutaneous injection, 10 units of semaglutide activate GLP-1 receptors, stimulating insulin secretion and inhibiting glucagon release. By regulating blood sugar levels, Semaglutide assists in improving glycemic control in adults with type 2 diabetes. It is crucial to follow the prescribed dosage and guidance provided by healthcare professionals for optimal therapeutic outcomes.